Lmr Partners LLP Biomarin Pharmaceutical Inc Call Options Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $4.09 Million - $5.07 Million	-55,000 Reduced 19.64%	225,000 $18.5 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $3.77 Million - $4.46 Million	45,000 Added 19.15%	280,000 $24.5 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $9.53 Million - $12.3 Million	125,000 Added 113.64%	235,000 $22.7 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $9.53 Million - $11 Million	110,000 New	110,000 $9.53 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.